ATX-202 Electronic app that produces promising results to reduce suicide attempts

Researchers from US “Yale” universities and “Ohio State” have revealed promising results to use an electronic application to tend to commit suicide, as the researchers confirmed the success of the application to reduce repeated suicide attempts by about 60% among psychiatric patients after leaving the hospital. The application, known as ATX-202, was developed to provide a psychological treatment for the prevention of suicide, and is an innovative digital solution to the critical gap that patients suffer after leaving the hospital, where they are in the most serious cases of psychological weakness. According to the study published in the Journal of the American Medical Association, patients who used the application showed a 58.3% decline in the repetition of suicide attempts after leaving the hospital, compared to a group that received the same traditional medical treatment but used another application that only contained information about awareness and safety plans. The ATX-202 influence was not limited to the prevention of suicide attempts, but users also showed a remarkable improvement in reducing suicide ideas, an improvement that lasted up to 24 weeks after leaving the hospital, while the comparison group saw an initial improvement that quickly disappeared. Digital drugs, and this application belongs to a new category of treatments known as ‘digital drugs’, which are some kind of technology -based medical interventions, which are usually offered by electronic applications or electronic platforms that are scientifically designed to treat or manage physical and psychological diseases. Unlike public health applications that help you detect the number of steps or sleep quality, digital drugs are subject to strict scientific tests, and this is evaluated, such as medication, and you often need the approval of the regulatory authorities such as the US FDA for food and drug administration. Digital drugs are based on deliberate behavioral or cognitive interventions, T. ET through interactive interfaces, such as cellphone applications or bearable devices, and are usually used under medical supervision. For example, a specialist application can help diabetics organize insulin doses by analyzing their daily data, or providing behavioral cognitive therapy sessions for depression and anxiety patients without visiting the clinic. Although digital treatments are not a direct alternative to medicine, it can be used with it or in some cases as a preliminary option. Some clinical trials have shown the effectiveness of some digital treatments or are better than the effectiveness of traditional medicine, especially in simple to medium psychological disorders, and the main advantage in this type of treatment is that it does not cause chemical side effects, and that patients give a greater ability to control their treatment path. “Specialized psychotherapy to prevent suicide attempts is very effective, but finding healers trained after leaving the hospital is a major challenge. The ATX-202 application can be a solution to this problem,” said the author of the ATX-202 application, such as the R-Brian, director of the suicide prevention program. The author who participated in the study explained Patricia Simon, a researcher at the Faculty of Medicine at Yale University, that the period following the suicide crises went directly and out of the hospital is one of the most dangerous periods that the regular suicide or death efforts can see, and emphasizes that ATX-202 is a dangerous gap. The data indicates that suicide is still one of the ten most important causes of death in the United States, which is the second cause of death between the age group of 10 to 14 years, from 25 to 34 years, and the third between the ages of 15 and 24, and the fourth in the category of 35 to 44 years. A high cost of suicide and catastrophic rates and since 1999 suicide figures in the United States have risen by more than 33%, and more than a million people participate in suicidal behavior annually, while about 500,000 people are transported to hospitals after committing suicide. The cost of suicide and suicide efforts to the US health system and the economy are estimated at about $ 500 billion annually. Despite this burden, suicide remains among the few deadly causes that have no licensed medication for most patients at risk. The new application has been tested in a clinical experience with a double -country, which includes 339 psychiatric patients from 6 different hospitals in the United States. The participants were randomly divided into two groups; A group that used the ATX-202 app, and others used a controlling application containing only a safety and psychological education plan, and both groups received the same ordinary medical treatment. The results were evaluated on the basis of the ‘clinical impression of the severity of the intensity of suicide’, which is an accredited scale that doctors use to measure changes in the symptoms of the patient and determine the extent of the improvement in a uniform. Facts and numbers on suicide, according to the World Health Organization, committed 720,000 people annually. Suicide is the third main cause of death between people between the ages of 15 and 29 all over the world. 73% of suicide cases occur in countries with low and medium income. Suicide efforts are more than complete cases, and an effort is a major risk factor to repeat the action. Suicide is a overall health problem that affects individuals, families and societies and fails long -term effects. Who is the most vulnerable to suicide? Those suffering from psychological disorders such as depression or addiction, especially in high -income countries. Those who experience sudden crises, such as: financial problems, family disputes or chronic pain. Poor groups such as refugees, migrants, indigenous peoples, homosexual people, sexual propensity, transgender and prisoners. People affected by conflicts, violence, disasters or loss of loved ones. How can your suicide prevent? According to the “Live Life” initiative launched by the World Health Organization, the access to suicide such as pesticides, firearms and some types of medicines limits. Improving responsible media coverage on the issue of suicide. Strengthening the skills of the social and emotional life of adolescents. Early detection, evaluation and follow -up -Up to individuals who are the risk of suicide. These interventions should be accompanied by supporting pillars such as analyzing the situation, awareness, financing, training, monitoring, evaluation and collaboration between different sectors. Challenges facing suicidal fighting efforts are the stigma and taboos prevents many people from seeking help or talking about their suicide ideas. A lack of accurate and updated data on cases and suicide efforts in many countries. The absence of national policy: Only 38 countries around the world have a clear strategy to prevent suicide. The lead author of the ATX-202 application, Seth Fuerchetein, the researcher Yale University, believes that “patients and people caring for it do not have effective and reliable instruments to reduce the risk of suicide in the future and face one of the biggest gaps to achieve treatment compared to any other important cause.” Seth emphasizes that the potential impact of this application on public health is ‘great’, pointing out that the scientific study in which he participated in the application and his experiences emphasized a fundamental shift in the way we handle suicide as a overall health crisis, instead of relying on traditional sessions after the hospital is left, providing the OTX-202 application. Personal, expansion and expansion, and he linked some time. The treatment remains limited or not available to many patients.